FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

CNBC
Mar 14, 2024

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease


The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide.

The FDA’s decision means Madrigal Pharmaceuticals has succeeded in a disease area that several larger companies have failed — or are still trying to break into. Madrigal shares jumped more than 20% in extended trading Thursday following the approval.

Share

Copied